Paul-Henri Lambert
Director/Miembro de la Junta en Hookipa Biotech AG .
Perfil
Paul-Henri Lambert is currently the Director of the International Advanced Vaccinology Course at the University of Geneva.
He also holds the position of Director of the International Advanced Vaccinology Course at Fondation Mérieux.
Additionally, he serves as a Member of the Supervisory Board at Hookipa Biotech AG.
Previously, he worked as the Director at HOOKIPA Pharma, Inc. from 2011 to 2019.
Cargos activos de Paul-Henri Lambert
Empresas | Cargo | Inicio |
---|---|---|
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Director/Miembro de la Junta | - |
Fondation Mérieux | Corporate Officer/Principal | 14/11/2013 |
University of Geneva | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Paul-Henri Lambert.
Empresas | Cargo | Fin |
---|---|---|
HOOKIPA PHARMA INC. | Director/Miembro de la Junta | 25/04/2019 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
HOOKIPA PHARMA INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Health Technology |
Fondation Mérieux | Miscellaneous |
- Bolsa de valores
- Insiders
- Paul-Henri Lambert